http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010228935-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a331d46449cc0bf0e1e9b8bda91158f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2010-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a31b9e431a7474d09da1a56f8b1be4ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_070a717f20600700a26bee048d7e4beb
publicationDate 2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2010228935-C1
titleOfInvention Compositions and methods for preferential distribution of active agents to injury sites
abstract Compositions are provided for preferential distribution of active agents to injury sites. Such compositions may comprise a ligand with hydrophilic properties and one or more active agents, such as compounds comprising hydrophilic metal ions. Because the delivery ligand and the active agent are specifically selected so the interactions between them are mainly of an ionic nature so that binding of the active agent to the delivery ligand and release of the active agent into the target site are not dependent on enzymatic activity. Methods of using such compositions are also disclosed.
priorityDate 2009-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007259044-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454669065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420961387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412630177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22182174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6455702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53477710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423387663
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4429391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968197
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32756
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1014
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420961534
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5770
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24766
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448452169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492924

Total number of triples: 53.